CRISPR Therapeutics
NasdaqGM:CRSP
$ 46,43
$-0,45 (-0,96%)
46,43 $
$-0,45 (-0,96%)
End-of-day quote: 03/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-6,47
Earnings Per Share
$0,04
Revenue Per Share
0,00%
Gross Margin %
$4,46 B
Market Cap
$0,04 B
Long-Term Debt
Earnings Per Share
$-6,47
Revenue Per Share
$0,04
Gross Margin %
0,00%
Market Cap
$4,46 B
Long-Term Debt
$0,04 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share $-6,47 $-4,34 $-1,94 $-8,36 $4,97 $-5,29 $1,17 $-3,44 $-1,71 $-6,39 $-4,20
Earnings Earnings $-621,06M $-372,24M $-155,74M $-657,51M $383,04M $-399,02M $71,19M $-179,84M $-80,34M $-254,39M $-23,23M
RPS Revenue Per Share $0,04 $0,44 $4,62 $0,02 $11,87 $0,01 $4,76 $0,06 $0,87 $0,13 $0,00
Revenue Revenue $3,51M $37,31M $371,21M $1,20M $914,96M $0,72M $289,59M $3,12M $41,00M $5,16M $0,00M
OCF Operating Cash Flow $-345,01M $-142,77M $-260,38M $-495,74M $538,97M $-238,37M $0,00M $-96,24M $0,00M $-55,31M $0,00M
FCF Free Cash Flow $-461,43M $-144,68M $-225,56M $-532,93M $457,27M $-256,72M $0,00M $-99,01M $0,00M $-58,33M $0,00M
OM Operating Margin 0,00% 0,00% -59,95% 0,00% 40,82% 0,00% 16,14% 0,00% -157,69% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% -39,43% 0,00% 51,72% 0,00% 38,06% 0,00% -70,26% 0,00% 0,00%
FCFS Free Cash Flow Per Share $-4,12 $-1,71 $-3,44 $-6,85 $6,02 $-3,89 $0,92 $-2,06 $-1,94 $-1,70 $11,57
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A $38,34M
Sha. Stocks 95,99M 85,77M 80,28M 78,65M 77,07M 75,43M 60,85M 52,28M 46,98M 39,81M 5,53M
×